ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,427.13
      -2.31%
      US Tech 100
      18,601.20
      -3.24%
      Dow Jones
      39,853.87
      -1.25%
      Brent Oil
      80.325
      -0.51%
      Bitcoin
      63,996.02
      -2.11%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. NewLink Genetics Corporation (NLNK)

      7. NewLink Genetics Corporation (NLNK) Financials

      NewLink Genetics Corporation

      NewLink Genetics Corporation (NLNK)

      NASDAQ
      0.89
      0.00
      (0.00%)
      Closed July 24 4:00PM
      Delayed by 15 minutes
      0.00
      0.00
      (0.00%)
      After Hours: -
      Delayed by 15 minutes

      NewLink Genetics Corporation Financial Summary

      The current NLNK market cap is 7.04M. The company's latest EPS is USD -4.2999 and P/E is -0.21.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 691k527k7k826k165k
      Operating Income -8.04M-9.64M-8.93M-10M-10.86M
      Net Income -7.35M-8.93M-8.3M-9.46M-10.44M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 936k168k230k1.52M2.05M
      Operating Income -45.13M-26.3M-31.35M-32.04M-36.61M
      Net Income -42.99M-5.66M-30.43M-31.06M-34.03M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 63.73M56.37M47.75M40.64M28.08M
      Total Liabilities 11.21M12.71M12.26M13.33M10.64M
      Total Equity 52.52M43.66M35.49M27.31M17.44M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 96.79M129.03M100.31M72.29M40.64M
      Total Liabilities 17.91M12.46M11.34M12.71M13.33M
      Total Equity 78.88M116.57M88.98M59.58M27.31M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -9.2M-15.88M-23.7M-31.1M-12.89M
      Investing -2.46M-1.38M4.57M10.74M1M
      Financing -309k-883k-1.32M-576k-5k
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -30.21M-23M-29.65M-26.62M-31.1M
      Investing 77k116.65M25.97M-11.36M10.74M
      Financing -59k75k-192k-821k-576k

      Stats and Ratios

      Market Cap 7.04M
      Price to Earnings Ratio -0.21
      Price to Sales Ratio 3.43
      Price to Cash Ratio 0.2
      Price to Book Ratio 0.26
      Dividend Yield -

      Share Statistics

      Shares Outstanding 7.92M
      Average Volume (1 week) 0
      Average Volume (1 Month) 0
      52 Week Change -
      52 Week High -
      52 Week Low -
      Spread (Intraday) 0.07 (7.1%)

      Company Info

      Company Name NewLink Genetics Corporation
      Address corporation trust center
      wilmington, delaware 19801
      Website https://lumos-pharma.com
      Industry pharmaceutical preparations (2834)